Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN)

33 filings reported holding ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q3 2021.
Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 8.43M shares of 79.6M outstanding shares and own 10.59% of the company stock.
Largest 10 shareholders include BVF INC/IL (1.36M shares), Logos Global Management LP (1.34M shares), Cormorant Asset Management, LP (1.31M shares), FMR LLC (1M shares), Woodline Partners LP (781K shares), VANGUARD GROUP INC (671K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (410K shares), Ikarian Capital, LLC (345K shares), Point72 Asset Management, L.P. (209K shares), and GEODE CAPITAL MANAGEMENT, LLC (128K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.